KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Restructuring Costs (2024)

Adaptive Biotechnologies (ADPT) has disclosed Restructuring Costs for 1 consecutive years, with $87000.0 as the latest value for Q4 2024.

  • Quarterly Restructuring Costs changed N/A to $87000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at $2.0 million for FY2024, N/A changed from the prior year.
  • Restructuring Costs hit $87000.0 in Q4 2024 for Adaptive Biotechnologies, down from $193000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.0 million in Q1 2024 to a low of $87000.0 in Q4 2024.